project44 Opens Paris Office to Accelerate European Expansion
project44, the global leader in advanced visibility for shippers and logistics service providers, today announced the opening of a new European office in Paris, France. project44 Senior Vice President of EMEA, Renaud Houri, will oversee the office and further build on project44’s European momentum, leading the company’s expanded growth across the region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191203006111/en/
project44 Senior Vice President of EMEA, Renaud Houri, will oversee the new Paris office and further build on project44’s European momentum, leading the company’s expanded growth across the region (Photo: Business Wire)
Following the acquisition of GateHouse Logistics, Europe’s leading visibility provider based in Denmark, in December 2018, project44 has built the largest visibility network available in the market representing coverage across more than 48 countries, integrations with 600+ telematics providers, and connections to more than 8.5M vehicles worldwide.
project44 has developed the industry’s only fully automated and secure carrier onboarding application, which can connect European Truckload carriers into its Advanced Visibility Platform™ within hours. Unlike other visibility providers that rely on manual onboarding methods, this unique approach to connectivity enables project44 to offer highly compliant advanced visibility coverage to its customers across Europe starting on day one.
“To meet evolving customer demands, global businesses are transforming their supply chains, requiring high-fidelity, real-time insight into their entire shipment process, regardless of region. Expanding our visibility coverage into new regions allows our customers to gain an end-to-end view into their global, multimodal shipments,” stated project44 Founder and CEO Jett McCandless. “Renaud has substantial experience helping global supply chains and organizations take a hyper-local approach. We’re excited to have him join the team and lead our European efforts.”
Prior to joining project44 in July 2019, Houri held various sales leadership positions at SaaS companies and in the logistics and transportation industry, including Senior Vice President of Global Business Development at Shippeo; Senior Vice President of Central, Eastern, and Southern Europe at Trace One; and Vice President and General Manager of EMEA at IBM DemandTec. His experience leading organizations in Europe for global companies will be imperative as project44 continues expansion in Europe and beyond.
“While many supply chains are global, it’s critical to understand the nuisances of local markets in order to streamline operations and reduce costs. project44 is dedicated to providing the value of a single visibility provider,” commented Houri. “I look forward to supporting organizations throughout Europe, enabling our customers to build a more efficient supply chain and provide an unmatched customer experience.”
As project44’s second European location, the Paris office will allow the visibility provider to better support customers across Europe. In addition to their European offices in Denmark and France, project44 has local teams in Germany, Netherlands, Italy, and Spain. With global customers, including many leading retailers, manufacturers and logistics service providers based in Europe, project44’s local teams are able to account for the distinct attributes of regional logistics operations, provide better support to customers across several time zones, and deliver documentation and materials in more than 13 languages.
To learn more visit www.project44.com or contact info@project44.com.
About project44
project44 is the world’s leading advanced visibility platform for shippers and logistics service providers. project44 connects, automates and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations are able to increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Truckload, Rail, Intermodal, and Ocean.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191203006111/en/
Contact information
Ally Lynch
ally@project44.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom